Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alan John Kingsman Insider Profile
4 Followers
Alan John Kingsman, Chairman at Oxford BioMedica, holds 15.03M shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Alan John Kingsman Bought $2,000,000 shares of Oxford BioMedica on Jan 10, 2011 for an estimated value of 100.00K.
Alan John Kingsman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Alan John Kingsman's holdings
Insider Roles
Chairman
Roles that Alan John Kingsman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alan John Kingsman
Alan John Kingsman's Trading History
List of latest transactions for each holding click on a transaction to see Alan John Kingsman's performance on stock
You May Also Like
Alan John Kingsman insider profile FAQ
What is the percentage of profitable transactions made by Alan John Kingsman?
The percentage of profitable transactions made by Alan John Kingsman is ―.
What is the average return per transaction made by Alan John Kingsman?
The average return per transaction made by Alan John Kingsman is ―.
What stocks does Alan John Kingsman hold?
Alan John Kingsman holds: OXBDF stocks.
What was Alan John Kingsman’s latest transaction?
Alan John Kingsman latest transaction was an Informative Buy of $100.00K.
What was Alan John Kingsman's most profitable transaction?
Alan John Kingsman’s most profitable transaction was an Informative Buy of OXBDF stock on January 10, 2011. The return on the trade was -10.00%.
What is Alan John Kingsman's role in Oxford BioMedica?
Alan John Kingsman's role in Oxford BioMedica is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.